Modulating anti-GD2 immunotherapy via dual DFMO and TGF-β inhibition in neuroblastoma

被引：0
|
作者：
Gandhi, Om H.
Turn, Christina S.
Liu, Kangning
Vu, Annette T.
Bassiri, Hamid
Hogarty, Michael D.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5122
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5122
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Idiotype network induced by anti-GD2 immunotherapy is associated with long-term survival in patients with neuroblastoma.
    Suzuki, Maya
    Cheung, Irene Y.
    Cheung, Nai-Kong V.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [42] Characterization of a Novel Human Anti-GD2 Anti-Idiotypic Antibody GK8 DNA Vaccine for Immunotherapy in Neuroblastoma
    Weixler, S.
    Fest, S.
    Zeng, Y.
    Huebener, N.
    Gaedicke, G.
    Krueger, J.
    Lode, H. N.
    EUROPEAN JOURNAL OF PEDIATRICS, 2009, 168 (03) : 377 - 377
  • [43] Characterization of a novel human anti-GD2 anti-idiotypic antibody GK8 DNA vaccine for immunotherapy in neuroblastoma
    Weixler, S.
    Fest, S.
    Huebener, N.
    Kruger, J.
    Gaedicke, G.
    Lode, H.
    ACTA PAEDIATRICA, 2008, 97 : 67 - 67
  • [44] DEVELOPMENT OF A NOVEL CELLULAR IMMUNOTHERAPY FOR NEUROBLASTOMA USING ANTI-GD2 ANTIBODY-PRODUCING MESENCHYMAL STEM CELLS
    Iguchi, Masafumi
    Yagyu, Shigeki
    Kambe, Kosuke
    Higashi, Mayumi
    Fumino, Shigehisa
    Kishida, Tsunao
    Iehara, Tomoko
    Mazda, Osam
    Tajiri, Tatsuro
    Ono, Shigeru
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S146 - S147
  • [45] Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy
    Gorostegui, Maite
    Munoz, Juan Pablo
    Perez-Jaume, Sara
    Simao-Rafael, Margarida
    Larrosa, Cristina
    Garraus, Moira
    Salvador, Noelia
    Lavarino, Cinzia
    Krauel, Lucas
    Mane, Salvador
    Castaneda, Alicia
    Mora, Jaume
    CANCERS, 2024, 16 (09)
  • [46] Bilateral tonic pupils secondary to anti-GD2 antibody therapy for neuroblastoma
    Edwards, Christopher M.
    Elefant, Daniel
    Isakoff, Michael S.
    Gaffar, Majida A.
    JOURNAL OF AAPOS, 2024, 28 (02):
  • [47] Lineage plasticity dictates responsiveness to anti-GD2 therapy in neuroblastoma.
    Mabe, Nathaniel W.
    Huang, Min
    Schaefer, Daniel A.
    Dalton, Guillermo N.
    Digiovanni, Giulia
    Alexe, Gabriela
    Geraghty, Anna C.
    Khalid, Delan
    Mader, Marius M.
    Sheffer, Michal
    Linde, Miles H.
    Ly, Nghi
    Rotiroti, Maria Caterina
    Smith, Benjamin A. H.
    Wernig, Marius
    Bertozzi, Carolyn R.
    Monje, Michelle
    Mitsiades, Constantine
    Majeti, Ravindra
    Satpathy, Ansuman T.
    Stegmaier, Kimberly
    Majzner, Robbie G.
    CANCER RESEARCH, 2022, 82 (23) : 3 - 3
  • [48] Dinutuximab: An Anti-GD2 Monoclonal Antibody for High-Risk Neuroblastoma
    Ploessl, Cady
    Pan, Alice
    Maples, Kathryn T.
    Lowe, Denise K.
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (05) : 416 - 422
  • [49] Development of a Novel Cellular Immunotherapy for Neuroblastoma using Anti-GD2 Antibody-Transduced Mesenchymal Stem Cells (Anti-GD2-MSC) - in vitro Results
    Iguchi, Masafumi
    Maniwa, Junnosuke
    Kambe, Kosuke
    Higashi, Mayumi
    Fumino, Shigehisa
    Aoi, Shigeyoshi
    Furukawa, Taizo
    Yagyu, Shigeki
    Mazda, Osam
    Tajiri, Tatsuro
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [50] SINUSOIDAL OBSTRUCTION SYNDROME CAUSED BY IL-2 INFUSION PRIOR TO ANTI-GD2 ANTIBODY IMMUNOTHERAPY FOR NEUROBLASTOMA: CASE REPORT
    Inoue, Shotaro
    Mori, Takeshi
    Hyodo, Sayaka
    Uemura, Suguru
    Saito, Atsuro
    Kozaki, Aiko
    Kishimoto, Kenji
    Ishida, Toshiaki
    Hasegawa, Daiichiro
    Kosaka, Yoshiyuki
    PEDIATRIC BLOOD & CANCER, 2022, 69
12345